On a roll…

The splicing factor U2AF1 contributes to cancer progression through a noncanonical role in translation regulation.

Lab co-author: Katie Lindblad

Molecular Measurable Residual Disease Testing of Blood During AML Cytotoxic Therapy for Early Prediction of Clinical Response.

Lab first author:  Hong Yuen 

Lab co-authors: Katie Lindblad, Sheenu, Greg, Meg, Matt, Nestor, Jingrong, Julie, Blair, Laura and Katie Lai.

MDS-associated mutations in germline GATA2 mutated patients with hematologic manifestations.

Lab Co-authors:  Hong Yuen, Jingrong, Matt.

Refining AML outcome prediction.

With more to come soon….